CLINTEC, Karolinska Institutet, Stockholm, Sweden.
Department of Otorhinolaryngology and Head and Neck Surgery and Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Int J Audiol. 2021 Nov;60(11):831-840. doi: 10.1080/14992027.2021.1886351. Epub 2021 Mar 9.
To assess the performance of newborn hearing screening (NHS) programmes, through selected quality measures and their relationship to protocol design.
NHS coverage, referral, follow-up and detection rates were aggregated. Referral rates were compared to age at screening step 1, number of steps, and test method: OAE or aABR.
A questionnaire on existing hearing screening was completed by experts from countries in Europe, plus Russia, Malawi, Rwanda, India and China.
Out of 47 countries or regions, NHS coverage rates were reported from 26, referral rates from 23, follow up from 12 and detection rates from 13. Median coverage rate for step 1 was 96%. Referral rate from step 1 was 6-22% where screening may be performed <24 h from birth, 2-15% for >24 h, and 4% for >72 h. Referral rates to diagnostic assessment averaged 2.1% after one to two steps using OAE only, 1.7% after two steps including aABR, and 0.8% after three to four steps including aABR. Median detection rate for bilateral permanent hearing impairment ≥40dB was 1 per 1000 infants.
Referral rates were related to age, test method and number of screening steps. Quality measures were not available for many NHS programmes.
通过选择的质量指标评估新生儿听力筛查 (NHS) 计划的性能及其与方案设计的关系。
汇总 NHS 覆盖率、转诊率、随访率和检出率。将转诊率与第 1 步筛查的年龄、筛查步骤数和测试方法(OAE 或 aABR)进行比较。
来自欧洲国家以及俄罗斯、马拉维、卢旺达、印度和中国的专家完成了一份关于现有听力筛查的问卷。
在 47 个国家或地区中,有 26 个报告了 NHS 覆盖率,23 个报告了转诊率,12 个报告了随访率,13 个报告了检出率。第 1 步的中位覆盖率为 96%。从第 1 步开始的转诊率为 6-22%,筛查可能在出生后<24 小时内进行,2-15%为>24 小时,4%为>72 小时。仅使用 OAE 进行 1 至 2 步筛查后,转诊至诊断评估的平均比例为 2.1%,包括 aABR 的 2 步筛查后为 1.7%,包括 aABR 的 3 至 4 步筛查后为 0.8%。双侧永久性听力损失≥40dB 的检出率中位数为每 1000 名婴儿 1 例。
转诊率与年龄、测试方法和筛查步骤数有关。许多 NHS 计划缺乏质量指标。